Tanzania is the most upcoming market in East Africa.
Around 16% of Tanzania’s GDP is formed by the export and import of goods and services.
In 2017, Tanzania's pharmatech market was valued at USD 600 million. Forecast shows that it would reach USD 830 million by 2023.
Tanzanian Pharma, Medical, Healthcare, Laboratory, Surgical & Orthopaedic market is likely to experience robust growth in the coming years.
The vast majority of pharma, medical and healthcare imports in Tanzania in the private sector supply chain are dominated by imports from India, Switzerland, Egypt, USA and South Africa.
Tanzanian authorities have reportedly been seeking collaborations with international pharmaceutical companies to promote the local development of medicines and technology.